Universal Health Services delivered a solid Q3 2025 with notable increases in revenue and net income, driven by strong performance across acute and behavioral health segments, and raised its full-year guidance.

UHS delivered solid performance in Q2 2025, driven by higher Medicaid reimbursements and growth across both acute and behavioral health segments.

Universal Health Services delivered strong revenue growth and earnings improvement, led by acute care services, despite cash flow pressures from delayed Medicaid payments.

Universal Health Services, Inc. reported Q4 2024 revenue of $4.11 billion, an increase of 11.1% year-over-year. Net income rose to $332.4 million, while adjusted EPS increased to $4.92. Revenue from acute care and behavioral health services grew by 8.7% and 11.1%, respectively. EBITDA net of NCI improved to $620.2 million, reflecting strong operational performance.

Universal Health Services, Inc. reported strong Q3 2024 results, with net revenues increasing by 11.2% to $3.963 billion and net income attributable to UHS reaching $258.7 million, or $3.80 per diluted share, compared to $167.0 million, or $2.40 per diluted share, in Q3 2023. Adjusted net income was $252.5 million, or $3.71 per diluted share. EBITDA net of NCI was $528.6 million, representing 13.3% of net revenues.

Universal Health Services, Inc. reported a strong second quarter in 2024, with net income attributable to UHS of $289.2 million, or $4.26 per diluted share, compared to $171.3 million, or $2.42 per diluted share, in the second quarter of 2023. Net revenues increased by 10.1% to $3.908 billion. The company also increased its full-year operating results forecast and announced a $1 billion increase to its stock repurchase program authorization.

Universal Health Services, Inc. reported a strong first quarter in 2024, with net income attributable to UHS reaching $261.8 million, or $3.82 per diluted share, compared to $163.1 million, or $2.28 per diluted share, in the first quarter of 2023. Net revenues also saw a substantial increase of 10.8% to $3.844 billion.

Universal Health Services, Inc. reported a net income attributable to UHS of $216.4 million, or $3.16 per diluted share, for the fourth quarter of 2023, compared to $174.8 million, or $2.43 per diluted share, for the fourth quarter of 2022. Net revenues increased by 7.4% to $3.704 billion during the fourth quarter of 2023, as compared to $3.447 billion during the fourth quarter of 2022.

Universal Health Services, Inc. reported a net income attributable to UHS of $167.0 million, or $2.40 per diluted share, for Q3 2023, compared to $182.8 million, or $2.50 per diluted share, for Q3 2022. Net revenues increased by 6.8% to $3.563 billion. Adjusted net income attributable to UHS was $177.5 million, or $2.55 per diluted share, compared to $185.8 million, or $2.54 per diluted share, for the same period last year.

Universal Health Services, Inc. reported a 6.8% increase in net revenues, reaching $3.548 billion in Q2 2023. Net income attributable to UHS was $171.3 million, or $2.42 per diluted share, compared to $164.1 million, or $2.20 per diluted share, in Q2 2022. Adjusted net income was $179.4 million, or $2.53 per diluted share.

Universal Health Services, Inc. reported a rise in net income attributable to UHS to $163.1 million, or $2.28 per diluted share, in Q1 2023, compared to $153.9 million, or $2.02 per diluted share, in Q1 2022. Net revenues also saw an increase of 5.3% to $3.468 billion during the same period.

Universal Health Services, Inc. reported a 5.2% increase in net revenues to $3.447 billion for the fourth quarter of 2022, compared to $3.275 billion in the fourth quarter of 2021. However, net income attributable to UHS decreased to $174.8 million, or $2.43 per diluted share, from $239.1 million, or $3.00 per diluted share, in the same period of the previous year. Adjusted net income attributable to UHS was $217.1 million, or $3.02 per diluted share, compared to $235.1 million, or $2.95 per diluted share, for the fourth quarter of 2021.

Universal Health Services, Inc. reported a decrease in net income attributable to UHS to $182.8 million, or $2.50 per diluted share, during the third quarter of 2022, compared to $218.4 million, or $2.60 per diluted share, during the third quarter of 2021. Net revenues increased by 5.7% to $3.336 billion during the third quarter of 2022 as compared to $3.156 billion during the third quarter of 2021.